NCT04462380: AiCR

AiCR : Artificial Intelligence in Cardiac aRrest

Status unknown Last updated 8 July 2020

What this trial tests

trial in Cardio Respiratory Arrest in 500 participants. Status unknown.

Timeline

1 February 2020

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nice
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 February 2020
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across France

Conditions studied

• Cardio Respiratory Arrest — all drugs for Cardio Respiratory Arrest →

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

18 and older, any sex, with Cardio Respiratory Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall incidence of cardiorespiratory arrest in Europe is estimated at 350,000 to 700,000 cases per year. Survival rate is estimated at 10.7% for all rhythm disorders combined.

Several examples of AI application in the medical field exist. Ting et al have developed a computer tool capable of diagnosing the presence of diabetic retinopathy with excellent power. In resuscitation, Celi et al proposed a tool capable of predicting the need for crystalloid vascular filling during a systemic inflammatory state. In Nature in 2018, Komorowski demonstrated the efficacy of AI in the hemodynamic management of sepsis. In a study of the renal response to fluid challenge, Zhang et al. demonstrate the effectiveness of the learning machine.

Objectives: Determination of an algorithm capable of predicting the mortality of patients admitted to intensive care units (ICU) for ACR from hospitalization reports (CRH). Also use of the algorithm to predict the risk of recurrence of the arrest, the duration of mechanical ventilation, the appearance of sepsis, the development of organ failure, prediction of the CPC (Cerebral Performance Category), time to obtain catecholamine withdrawal, the appearance of acute renal failure with or without the need for extra-renal purification (EER) and duration under EER, the average length of stay.

This project is part of a larger, nationwide project with greater power, and includes all the data generated during hospitalization in intensive care.

Method: an estimated total number of patients included in this study to be between 300 and 500. The population will come from the intensive care units of Nice, Antibes, Cannes, Grasse.

Inclusion will be retrospective, on CRH, CR of CT imaging (cerebral and thoraco-abdomino-pelvic), MRI, EEG, and daily follow-up words, from 2014 to the end of 2020.

After anonymisation, application of semantisation using natural language processing (NLP) methods. The data to be extracted are entered in a document written by intensive care physicians. These data will then be stored in a database. In order to meet the main objective, we will develop a computer algorithm capable of predicting mortality in the study population. This algorithm, based on a large database, can be designed using machine learning or even deep learning techniques depending on the amount of data to be processed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.